Other Species / Isoforms
  CD5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K79-ub
EDPSQASkVCQRLNC
0 1
CD5 (human) EDPSQASkVCQRLNC K79-ub
CD5 (mouse) KNAQQASAVCKQLRC A78
CD5 (rat) KNANEASTVCQQLGC T77
S186-p
GSLGGTIsYEAQDKT
0 1
CD5 (human) GSLGGTIsYEAQDKT S186-p
CD5 (mouse) GSWGGTILYKAKDRP L186
CD5 (rat) GSRGGTILYKAKARP L184
K211-ub
LQCGSFLkHLPETEA
0 1
CD5 (human) LQCGSFLkHLPETEA K211-ub
CD5 (mouse) LQCGSFLTHLSGTEA T211
CD5 (rat) LQCGSFLTHLSRIET T209
K273-ub
LCSGFQPkVQSRLVG
0 1
CD5 (human) LCSGFQPkVQSRLVG K273-ub
CD5 (mouse) ICSDFQPKVQSRLVG K273
CD5 (rat) VCSDFQPKVQSRLVG K271
K346-ub
GLFCPHQkLSQCHEL
0 1
CD5 (human) GLFCPHQkLSQCHEL K346-ub
CD5 (mouse) GFLCAQEKLSQCYHL K345
CD5 (rat) GVLCTQEKLSQCYQL K343
K361-ub
WERNSYCkKVFVTCQ
0 1
CD5 (human) WERNSYCkKVFVTCQ K361-ub
CD5 (mouse) under review -
CD5 (rat) under review -
T421-p
QRQWIGPtGMNQNMs
0 2
CD5 (human) QRQWIGPtGMNQNMs T421-p
CD5 (mouse) QRQWIGPTGVNQNMS T420
CD5 (rat) QRQWIGPTGVNQSMS T417
S428-p
tGMNQNMsFHRNHtA
0 11
CD5 (human) tGMNQNMsFHRNHtA S428-p
CD5 (mouse) TGVNQNMSFHRSHTA S427
CD5 (rat) TGVNQSMSFHRSHTA S424
T434-p
MsFHRNHtAtVRsHA
Upstream
Downstream
1 44
Effects on Modified Protein
  • activity, induced
  • receptor internalization, altered
Kinase, in vitro:
  • PKCA (rat)
  • PKCB (rat)
  • PKCG (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • GF109203X
  • phorbol_ester
  • staurosporine
CD5 (human) MsFHRNHtAtVRsHA T434-p
CD5 (mouse) MSFHRSHTATVRSQV T433
CD5 (rat) MSFHRSHTATVRSQV T430
T436-p
FHRNHtAtVRsHAEN
Upstream
Downstream
1 44
Effects on Modified Protein
  • activity, induced
  • receptor internalization, altered
Kinase, in vitro:
  • PKCA (rat)
  • PKCB (rat)
  • PKCG (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • GF109203X
  • phorbol_ester
  • staurosporine
CD5 (human) FHRNHtAtVRsHAEN T436-p
CD5 (mouse) FHRSHTATVRSQVEN T435
CD5 (rat) FHRSHTATVRSQVEN T432
S439-p
NHtAtVRsHAENPtA
Upstream
0 203
Treatment
  • U0126
CD5 (human) NHtAtVRsHAENPtA S439-p
CD5 (mouse) SHTATVRSQVENPTA S438
CD5 (rat) SHTATVRSQVENPAA S435
T445-p
RsHAENPtAsHVDNE
0 18
CD5 (human) RsHAENPtAsHVDNE T445-p
CD5 (mouse) RSQVENPTASHVDNE T444
CD5 (rat) RSQVENPAASHVDNE A441
S447-p
HAENPtAsHVDNEys
0 15
CD5 (human) HAENPtAsHVDNEys S447-p
CD5 (mouse) QVENPTASHVDNEyS S446
CD5 (rat) QVENPAASHVDNEYS S443
Y453-p
AsHVDNEysQPPRNs
Upstream
Downstream
5 295
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • Fyn (human)
  • Lck (human)
Putative in vivo kinases:
  • Lck (human)
Regulatory protein:
  • ZAP70 (human)
Treatment
  • anti-CD28
  • anti-CD3
  • U0126
  • vanadate
CD5 (human) AsHVDNEysQPPRNs Y453-p
CD5 (mouse) ASHVDNEySQPPRNS Y452-p
CD5 (rat) ASHVDNEYSQPPRNS Y449
S454-p
sHVDNEysQPPRNsH
0 108
CD5 (human) sHVDNEysQPPRNsH S454-p
CD5 (mouse) SHVDNEySQPPRNSH S453
CD5 (rat) SHVDNEYSQPPRNSR S450
S460-p
ysQPPRNsHLSAyPA
0 1
CD5 (human) ysQPPRNsHLSAyPA S460-p
CD5 (mouse) ySQPPRNSHLSAyPA S459
CD5 (rat) YSQPPRNSRLSAYPA S456
Y465-p
RNsHLSAyPALEGAL
3 20
CD5 (human) RNsHLSAyPALEGAL Y465-p
CD5 (mouse) RNSHLSAyPALEGAL Y464-p
CD5 (rat) RNSRLSAYPALEGAL Y461
S476-p
EGALHRSsMQPDNss
Upstream
0 1
Treatment
  • anti-CD3
CD5 (human) EGALHRSsMQPDNss S476-p
CD5 (mouse) EGALHRSStQPDNSs S475
CD5 (rat) EGALHRSSTQPDNss S472
M477
GALHRSsMQPDNssD
0 1
CD5 (human) GALHRSsMQPDNssD M477
CD5 (mouse) GALHRSStQPDNSsD T476-p
CD5 (rat) GALHRSSTQPDNssD T473
S482-p
SsMQPDNssDsDyDL
Upstream
1 22
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • heparin sodium
  • phorbol_ester
CD5 (human) SsMQPDNssDsDyDL S482-p
CD5 (mouse) SStQPDNSsDsDyDL S481
CD5 (rat) SSTQPDNssDsDYDL S478-p
S483-p
sMQPDNssDsDyDLH
Upstream
1 68
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • heparin sodium
  • phorbol_ester
CD5 (human) sMQPDNssDsDyDLH S483-p
CD5 (mouse) StQPDNSsDsDyDLQ S482-p
CD5 (rat) STQPDNssDsDYDLQ S479-p
S485-p
QPDNssDsDyDLHGA
Upstream
1 18
Kinase, in vitro:
  • CK2A1 (human)
Putative in vivo kinases:
  • CK2A1 (human)
Treatment
  • heparin sodium
  • phorbol_ester
CD5 (human) QPDNssDsDyDLHGA S485-p
CD5 (mouse) QPDNSsDsDyDLQVA S484-p
CD5 (rat) QPDNssDsDYDLQVA S481-p
Y487-p
DNssDsDyDLHGAQR
Upstream
4 90
Kinase, in vitro:
  • Fyn (human)
  • Lck (human)
Putative in vivo kinases:
  • Lck (human)
Treatment
  • anti-CD3
  • vanadate
CD5 (human) DNssDsDyDLHGAQR Y487-p
CD5 (mouse) DNSsDsDyDLQVAQR Y486-p
CD5 (rat) DNssDsDYDLQVAQR Y483